STELLANTIS NV (STLAP.PA) Fundamental Analysis & Valuation

EPA:STLAP • NL00150001Q9

Current stock price

6.592 EUR
+0.27 (+4.25%)
Last:

This STLAP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. STLAP.PA Profitability Analysis

1.1 Basic Checks

  • STLAP had positive earnings in the past year.
  • In the past year STLAP has reported a negative cash flow from operations.
  • Of the past 5 years STLAP 4 years were profitable.
  • Of the past 5 years STLAP 4 years had a positive operating cash flow.
STLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFSTLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B -20B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.19%, STLAP is doing worse than 66.67% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -3.27%, STLAP is doing worse than 63.33% of the companies in the same industry.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
STLAP.PA Yearly ROA, ROE, ROICSTLAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • STLAP has a Gross Margin of 7.74%. This is amonst the worse of the industry: STLAP underperforms 80.00% of its industry peers.
  • STLAP's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for STLAP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
STLAP.PA Yearly Profit, Operating, Gross MarginsSTLAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

2

2. STLAP.PA Health Analysis

2.1 Basic Checks

  • STLAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STLAP has been increased compared to 1 year ago.
  • The number of shares outstanding for STLAP has been increased compared to 5 years ago.
  • The debt/assets ratio for STLAP is higher compared to a year ago.
STLAP.PA Yearly Shares OutstandingSTLAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
STLAP.PA Yearly Total Debt VS Total AssetsSTLAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

2.2 Solvency

  • STLAP has an Altman-Z score of 1.31. This is a bad value and indicates that STLAP is not financially healthy and even has some risk of bankruptcy.
  • STLAP has a Altman-Z score (1.31) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.38 indicates that STLAP is not too dependend on debt financing.
  • STLAP has a better Debt to Equity ratio (0.38) than 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACC6.58%
STLAP.PA Yearly LT Debt VS Equity VS FCFSTLAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

  • STLAP has a Current Ratio of 1.06. This is a normal value and indicates that STLAP is financially healthy and should not expect problems in meeting its short term obligations.
  • STLAP's Current ratio of 1.06 is on the low side compared to the rest of the industry. STLAP is outperformed by 66.67% of its industry peers.
  • A Quick Ratio of 0.77 indicates that STLAP may have some problems paying its short term obligations.
  • STLAP has a worse Quick ratio (0.77) than 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
STLAP.PA Yearly Current Assets VS Current LiabilitesSTLAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

3

3. STLAP.PA Growth Analysis

3.1 Past

  • The earnings per share for STLAP have decreased strongly by -16.56% in the last year.
  • The Earnings Per Share has been growing by 31.54% on average over the past years. This is a very strong growth
  • Looking at the last year, STLAP shows a decrease in Revenue. The Revenue has decreased by -2.15% in the last year.
  • STLAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.93% yearly.
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.15% on average over the next years.
  • STLAP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.56% yearly.
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STLAP.PA Yearly Revenue VS EstimatesSTLAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B 200B
STLAP.PA Yearly EPS VS EstimatesSTLAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6

6

4. STLAP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.47, the valuation of STLAP can be described as very cheap.
  • 93.33% of the companies in the same industry are more expensive than STLAP, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of STLAP to the average of the S&P500 Index (25.51), we can say STLAP is valued rather cheaply.
  • The Price/Forward Earnings ratio is 1.76, which indicates a rather cheap valuation of STLAP.
  • Based on the Price/Forward Earnings ratio, STLAP is valued cheaper than 93.33% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.76. STLAP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.47
Fwd PE 1.76
STLAP.PA Price Earnings VS Forward Price EarningsSTLAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of STLAP indicates a somewhat cheap valuation: STLAP is cheaper than 63.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.24
STLAP.PA Per share dataSTLAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • A more expensive valuation may be justified as STLAP's earnings are expected to grow with 27.09% in the coming years.
PEG (NY)N/A
PEG (5Y)0.08
EPS Next 2Y18.5%
EPS Next 3Y27.09%

0

5. STLAP.PA Dividend Analysis

5.1 Amount

  • No dividends for STLAP!.
Industry RankSector Rank
Dividend Yield 0%

STLAP.PA Fundamentals: All Metrics, Ratios and Statistics

STELLANTIS NV

EPA:STLAP (4/2/2026, 5:29:40 PM)

6.592

+0.27 (+4.25%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners48.13%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap19.14B
Revenue(TTM)153.51B
Net Income(TTM)-2.39B
Analysts70.56
Price Target8.45 (28.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.68
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.99%
PT rev (3m)-13.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-39.14%
EPS NY rev (3m)-37.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 2.47
Fwd PE 1.76
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 0.82
EV/EBITDA 5.24
EPS(TTM)2.67
EY40.5%
EPS(NY)3.75
Fwd EY56.88%
FCF(TTM)-5.52
FCFYN/A
OCF(TTM)-1.9
OCFYN/A
SpS50.32
BVpS25.18
TBVpS8.03
PEG (NY)N/A
PEG (5Y)0.08
Graham Number38.89
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.31
F-Score1
WACC6.58%
ROIC/WACCN/A
Cap/Depr(3y)139.68%
Cap/Depr(5y)144.78%
Cap/Sales(3y)6.13%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%
EBIT growth 1Y-114.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1048.17%
EBIT Next 3Y151.99%
EBIT Next 5Y84.65%
FCF growth 1Y-767.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.82%
OCF growth 3YN/A
OCF growth 5YN/A

STELLANTIS NV / STLAP.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to STLAP.PA.


What is the valuation status for STLAP stock?

ChartMill assigns a valuation rating of 6 / 10 to STELLANTIS NV (STLAP.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for STELLANTIS NV?

STELLANTIS NV (STLAP.PA) has a profitability rating of 1 / 10.


How financially healthy is STELLANTIS NV?

The financial health rating of STELLANTIS NV (STLAP.PA) is 2 / 10.


What is the expected EPS growth for STELLANTIS NV (STLAP.PA) stock?

The Earnings per Share (EPS) of STELLANTIS NV (STLAP.PA) is expected to decline by -62.6% in the next year.